The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 03, 2012
Filed:
May. 18, 2009
Martin C. Clasby, Plainsboro, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Yan Xia, Edison, NJ (US);
Tin-yau Chan, Edison, NJ (US);
Mariappan V. Chelliah, Edison, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
Haiyan Pu, Livingston, NJ (US);
Keith A. Eagen, Long Valley, NJ (US);
Henry Vaccaro, South Plainfield, NJ (US);
Brian A. Mckittrick, New Vernon, NJ (US);
Liyuan Wang, Warren, NJ (US);
Xiaobang Gao, Conshohocken, PA (US);
Martin C. Clasby, Plainsboro, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Yan Xia, Edison, NJ (US);
Tin-Yau Chan, Edison, NJ (US);
Mariappan V. Chelliah, Edison, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
Haiyan Pu, Livingston, NJ (US);
Keith A. Eagen, Long Valley, NJ (US);
Henry Vaccaro, South Plainfield, NJ (US);
Brian A. McKittrick, New Vernon, NJ (US);
Liyuan Wang, Warren, NJ (US);
Xiaobang Gao, Conshohocken, PA (US);
Schering Corporation, Kenilworth, NJ (US);
Abstract
The present invention relates to novel heterocyclic compounds of Formulae I-III; as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.